PT - JOURNAL ARTICLE AU - Shiri, Alireza Hashemi AU - Raiatdoost, Esmaeil AU - Afkhami, Hamid AU - Ravanshad, Ruhollah AU - Hosseini, Seyed Ehsan AU - Kalani, Navid AU - Raoufi, Rahim TI - The herbal combination of Sugarcane, Black Myrobalan, and mastic as a supplementary treatment for COVID-19: a randomized clinical trial AID - 10.1101/2021.04.27.21256221 DP - 2021 Jan 01 TA - medRxiv PG - 2021.04.27.21256221 4099 - http://medrxiv.org/content/early/2021/04/28/2021.04.27.21256221.short 4100 - http://medrxiv.org/content/early/2021/04/28/2021.04.27.21256221.full AB - Background Given the COVID-19 pandemic’s, researchers are beseeched for effective treatments. Herbal medicine is also queried for potential supplementary treatments for COVID-19. We aimed to evaluate the effects of Sugarcane, Black Myrobalan, and Mastic herbal medications for COVID-19 patients.Methods This was a double-blinded randomized clinical trial study conducted over three months from May to July 2020 in patients admitted with a diagnosis of COVID-19 in Peymaniyeh Hospital in Jahrom, Iran. The intervention group received the treatment protocol approved by the Ministry of Health of Iran during the period of hospitalization and the herbal supplement obtained from the combination of black myrobalan and mastic and sugarcane, twice a day (3g of herbal supplements). All patients were compared in terms of demographic variables, vital signs, clinical and laboratory variables.Results 72 patients with COVID-19, divided into intervention (n=37) and control (n=35) groups. intervention and control groups had not any significant difference in terms of baseline characteristics. The time-to-event analysis revealed a significant difference in 4 symptoms of cough, fever, dyspnea, and myalgia (P<0.05). The Control group had a significantly lower decrease in C-reactive protein during 7 days (P<0.05). Patients in the herbal supplement group were hospitalized for 4.12 days and in the control group were hospitalized for 8.37 days (P=0.001). ICU admission and death only happened in 3 (8.6%) patients of the control group.Conclusion While advanced studies with more sample size are needed; the proposed combination seems to be effective in the symptom treatment and reducing the length of hospitalization.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIRCT20200415047082N1Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee of Jahrom University of Medical Sciences under the ethical code IR.JUMS.REC.1399.003 and was registered in the Iranian registry of clinical trials under the number IRCT20200415047082N1.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant and studied data are available in all versions of this manuscript.ALTAlanine aminotransferaseAHAAmerican Heart AssociationASTAspartate aminotransferaseBUNBlood urea nitrogenBMIBody mass indexCrCreatinineDBPDiastolic blood pressureHBHemoglobinINRInternational normalized ratioPTTPartial thromboplastin timePTProthrombin timePRPulse rateRBCSRed blood cellsRRRespiratory rateSBPSystolic blood pressureTIMTraditional Iranian MedicineWBCSWhite blood cells